AnaptysBio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.About ANAB
AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.
ANAB Key Statistics
Stock Snapshot
As of today, AnaptysBio(ANAB) shares are valued at $55.46. The company's market cap stands at 1.59B, with a P/E ratio of -106.55.
As of 2026-03-31, AnaptysBio(ANAB) stock has fluctuated between $55.12 and $60.08. The current price stands at $55.46, placing the stock +0.6% above today's low and -7.7% off the high.
The AnaptysBio(ANAB)'s current trading volume is 804.07K, compared to an average daily volume of 755.94K.
In the last year, AnaptysBio(ANAB) shares hit a 52-week high of $68.39 and a 52-week low of $15.40.
In the last year, AnaptysBio(ANAB) shares hit a 52-week high of $68.39 and a 52-week low of $15.40.
ANAB News
Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on AnaptysBio. The associated price target was raised to $66.00. End of Quarter Sale -...
AnaptysBio has approved the spin off of First Tracks Biotherapeutics, with shareholders set to receive one First Tracks share for each AnaptysBio share held. F...
AnaptysBio (ANAB) has drawn attention after its recent share performance, with the stock showing negative returns over the past week, alongside positive moves o...
Analyst ratings
92%
of 12 ratingsMore ANAB News
An announcement from AnaptysBio ( (ANAB) ) is now available. AnaptysBio, Inc. is a biotechnology company that is spinning out First Tracks Biotherapeutics as a...
(RTTNews) - AnaptysBio Inc. (ANAB), on Friday, announced that its board has authorized a stock repurchase plan of up to $100 million and provided a business upd...
AnaptysBio (ANAB) announced that its board of directors has authorized a stock repurchase plan under which the company may repurchase up to $100M of the company...
AnaptysBio (ANAB) announced that its board of directors has approved the previously announced spin-off of First Tracks Biotherapeutics. The new company is expec...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.